辨体调周补肾法治疗不同体型多囊卵巢综合征76例
|
摘要
目的:观察辨体调周补肾法治疗不同体型多囊卵巢综合征患者的效果。方法:应用辨体调周补肾法治疗多囊卵巢综合征患者76例,根据BMI分为肥胖组39例,非肥胖组37例。治疗3个月,观察两组临床疗效、排卵率、月经量表评分、治疗前后T、LH/FSH水平。结果:肥胖组、非肥胖组总有效率分别为71.79%、72.97%,两组总有效率比较差异无统计学意义(P>0.05)。肥胖组、非肥胖组排卵率分别为53.84%、59.45%,两组排卵率比较差异无统计学意义(P>0.05)。肥胖组、非肥胖组治疗后T、LH/FSH、月经量表评分比较,差异均无统计学意义(P>0.05)。治疗后,肥胖组、非肥胖组T、LH/FSH、月经量表评分与治疗前比较,差异均有统计学意义(P<0.01)。结论:辨体调周补肾法能够有效降低多囊卵巢综合征患者性激素T、LH/FSH水平,改善临床症状,对不同体型患者均有较好的临床疗效。
Objective:To observe the clinical efficacy of Bianti Tiaozhou Bushen therapy for different body size of polycystic ovary syndrome(PCOS).Method:Bianti Tiaozhou Bushen therapy was used to treat 76 cases of PCOS,and according to BMI,39 cases were divided into the obese group and 37 cases were divided into the non-obese group.The clinical efficacy,ovulation rate,menstrual scale score,T and LH/FSH levels before and after treatment were observed.Result:The obese group and the non-obese group total effective rate was 71.79% and 72.97% respectively.Comparison of total efficiency between the two groups,and the difference was not statistically significant(P>0.05).The obese group and the non-obese group total ovulation rate was 53.84% and 59.45%.Comparison of ovulation rate between the two groups,and the difference was not statistically significant(P>0.05).Comparison of T,LH/FSH and menstrual scale scores between the obese group and the non-obese group after treatment,the differences were not statistically significant(P>0.05).After treatment,T,LH/FSH and menstrual scale scores of the obese group and the non-obese group were compared with those before treatment,the differences were statistically significant(P<0.01).Conclusion:Bianti Tiaozhou Bushen therapy can effectively reduce levels of sex hormone T and LH/FSH in patients with polycystic ovary syndrome and improve clinical symptoms,and for patients of different body size have good clinical efficacy.
Objective:To observe the clinical efficacy of Bianti Tiaozhou Bushen therapy for different body size of polycystic ovary syndrome(PCOS).Method:Bianti Tiaozhou Bushen therapy was used to treat 76 cases of PCOS,and according to BMI,39 cases were divided into the obese group and 37 cases were divided into the non-obese group.The clinical efficacy,ovulation rate,menstrual scale score,T and LH/FSH levels before and after treatment were observed.Result:The obese group and the non-obese group total effective rate was 71.79% and 72.97% respectively.Comparison of total efficiency between the two groups,and the difference was not statistically significant(P>0.05).The obese group and the non-obese group total ovulation rate was 53.84% and 59.45%.Comparison of ovulation rate between the two groups,and the difference was not statistically significant(P>0.05).Comparison of T,LH/FSH and menstrual scale scores between the obese group and the non-obese group after treatment,the differences were not statistically significant(P>0.05).After treatment,T,LH/FSH and menstrual scale scores of the obese group and the non-obese group were compared with those before treatment,the differences were statistically significant(P<0.01).Conclusion:Bianti Tiaozhou Bushen therapy can effectively reduce levels of sex hormone T and LH/FSH in patients with polycystic ovary syndrome and improve clinical symptoms,and for patients of different body size have good clinical efficacy.
引文
[1]曹泽毅.中华妇产科学(下册)[M].北京:人民卫生出版社,2004:2449.
[2]肖虎,凌最荣,章琴.多囊卵巢综合征患者血脂代谢的特点分析[J].中华内分泌代谢杂志,2014,30(2):139-142.
[3] Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertility and Sterility,2004,81(1):19-25.
[4]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:29-31.
[5]张玉珍.中医妇科学[M].北京:中国中医药出版社,2006:115-116.
[6]徐莲薇,倪晓容,叶玉妹.补肾活血调周法治疗多囊卵巢综合征疗效观察[J].上海中医药杂志,2008,42(12):37-39.
[7]牛彩琴,张蜀,雷枭雄,等.中医论治青春期肥胖型多囊卵巢综合征的临床疗效[J].川北医学院学报,2016,31(4):500-501.
[8]许华云,付金荣.蔡小荪治疗多囊卵巢综合征致不孕症经验[J].辽宁中医杂志,2012,39(8):1466-1468.
[9]赵洁,褚玉霞.褚玉霞教授治疗多囊卵巢综合征致不孕症经验[J].中国中医药现代远程教育,2015,13(24):25-26.
[10]陈婕,谈勇.中药调周法治疗PCOS不孕症疗效的Meta分析[J].中国中医基础医学杂志,2017,23(10):1417-1421.
[11]李红.吕绍光临证经验撷萃[M].北京:中国中医药出版社,2015:118.
[12]曹泽毅,翁梨驹,郎景和,等.中华妇产科学[M].第2版.北京:人民卫生出版社,2008:2454-2455.
[2]肖虎,凌最荣,章琴.多囊卵巢综合征患者血脂代谢的特点分析[J].中华内分泌代谢杂志,2014,30(2):139-142.
[3] Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertility and Sterility,2004,81(1):19-25.
[4]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:29-31.
[5]张玉珍.中医妇科学[M].北京:中国中医药出版社,2006:115-116.
[6]徐莲薇,倪晓容,叶玉妹.补肾活血调周法治疗多囊卵巢综合征疗效观察[J].上海中医药杂志,2008,42(12):37-39.
[7]牛彩琴,张蜀,雷枭雄,等.中医论治青春期肥胖型多囊卵巢综合征的临床疗效[J].川北医学院学报,2016,31(4):500-501.
[8]许华云,付金荣.蔡小荪治疗多囊卵巢综合征致不孕症经验[J].辽宁中医杂志,2012,39(8):1466-1468.
[9]赵洁,褚玉霞.褚玉霞教授治疗多囊卵巢综合征致不孕症经验[J].中国中医药现代远程教育,2015,13(24):25-26.
[10]陈婕,谈勇.中药调周法治疗PCOS不孕症疗效的Meta分析[J].中国中医基础医学杂志,2017,23(10):1417-1421.
[11]李红.吕绍光临证经验撷萃[M].北京:中国中医药出版社,2015:118.
[12]曹泽毅,翁梨驹,郎景和,等.中华妇产科学[M].第2版.北京:人民卫生出版社,2008:2454-2455.